Jiangsu Hengrui Pharma A/H Listing - Low-End Is Probably Close to Fair Value
Jiangsu Hengrui Medicine (600276 CH), a China-based pharmaceutical company, aims to raise around US$1.3bn in its H-share listing. In this note, we...
638 Views
Quiddity Leaderboard HSTECH Jun25: US$1.85bn One-Way; Announcement Soon
We estimate one-way flows of US$1.85bn which translates to a turnover of 8.4%. Some names are expected to see large index inflows due to upward...
454 Views
[Blue Lotus Daily-TMT Update]:JD US/3690 HK/700 HK/1024 HK/BILI US/BIDU US/BABA US
​JD and Meituan raise standards for premium food delivery, Tencent releases new AI model, Bilibili launches AI advertising tool.
224 Views
HK Short Interest Weekly: Baba, CCB, Jd
We analyzed the latest HK SFC report for aggregate short position as of May 2nd and highlight short interest changes in Baba, CCB, Jd.
544 Views
CATL A/H Listing - More like ADR Secondary Listing than an A/H Listing - Performance & Subscription
Contemporary Amperex Technology (CATL) (300750 CH) , one of the world’s largest battery solutions providers, aims to raise around US$4bn in its H...
678 Views